Nasdaq
Trinity Biotech Regains Nasdaq Compliance
The firm had received notice last year that it was out of compliance with a requirement to maintain a minimum $15 million market value of publicly held shares.
Nasdaq to Delist Centogene
The German firm did not appeal the decision and will be delisted after having failed to achieve certain milestones to retain its status as a listed company.
OpGen Shares Suspended From Trading on Nasdaq
The suspension comes as the molecular diagnostics firm struggles to meet the Nasdaq's minimum stockholders’ equity requirement.
Centogene Delisted From Nasdaq
The German rare disease company expects its common stock to begin trading on the OTC Markets Group platform on Aug. 8 under the ticker symbol CNTGF.
360Dx Top 30 Jumps 11 Percent in July
Of the 30 companies in the index, 27 saw their share prices increase, while three saw their stock prices decline.